BBOT to Participate in the Jefferies Global Healthcare Conference in London
Globenewswire·2025-11-03 21:05
SOUTH SAN FRANCISCO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced that members of its leadership team will participate in a presentation at the Jefferies Global Healthcare Conference on Monday, November 17, at 2:30 p.m. GMT. A live webcast of the presentation will be accessible on the “Events” page of the BBOT website at https://investors.bbotx.com/news ...